Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme

J. Nelissen, P. Lemkens, H. Sann, M. Bindl, F. Bassissi, D. Jasserand, J. G. R. De Mey, B. J. A. Janssen

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)587-592
JournalLife Sciences
Volume91
Issue number13-14
DOIs
Publication statusPublished - 15 Oct 2012

Keywords

  • Endothelin converting enzyme
  • Neutral endopeptidase
  • Calcitonin gene-related peptide
  • Metalloproteases
  • Kidney

Cite this